Imprecision in tuberculosis infection outcomes: implications for non-inferiority vaccine trials

Key Points

• The research examines the design and interpretation of non-inferiority trials for tuberculosis vaccines focusing on infection outcomes.
• Analysis of existing tuberculosis vaccine trials
• Assessment of measurement tools for infection outcomes
• Evaluation of non-inferiority trial design
• Highlighted potential risks of declaring non-inferiority falsely
• Emphasized the importance of tool specificity in trial outcomes
• Suggested improvements for trial methodologies